Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	45.91	275.19	-78.96	-127.39	-125.55	-66.15
Depreciation & Amortization	2.68	2.9	3.31	3.37	2.78	2.72
Loss (Gain) From Sale of Investments	-8.64	-8.88	-4.57	-0.55	1.83	0.04
Stock-Based Compensation	44.37	37.55	29.29	24.2	16.4	7.9
Other Operating Activities	-	-	0.19	-	-	2.02
Change in Accounts Receivable	-0.58	-155	-9.99	1.56	0.86	4.33
Change in Accounts Payable	2.6	0.84	-2.87	2.05	-1.39	0.31
Change in Unearned Revenue	-19.22	30.57	-	-1.6	-12.88	-27.05
Change in Income Taxes	-1.05	2.69	-	-	-	-
Change in Other Net Operating Assets	-0.6	-1.71	-6.65	-9.77	10.09	3.4
Operating Cash Flow	65.47	184.15	-70.24	-108.14	-107.87	-72.48
Capital Expenditures	-1.76	-1.36	-0.61	-0.8	-1.1	-0.47
Investment in Securities	-105.12	-298.13	-38.65	92.26	-14.76	-90.49
Investing Cash Flow	-106.87	-299.48	-39.26	91.47	-15.86	-90.97
Long-Term Debt Repaid	-	-	-	-	-	-10.52
Net Debt Issued (Repaid)	-	-	-	-	-	-10.52
Issuance of Common Stock	24.54	26.45	171.25	19	130.11	258.16
Repurchase of Common Stock	-0.48	-0.6	-0.77	-0.19	-0.19	-
Other Financing Activities	-	-	-	0.03	-	-0.01
Financing Cash Flow	24.06	25.85	170.48	18.84	129.92	247.63
Foreign Exchange Rate Adjustments	-	-	-	-0.09	-0.13	0.18
Net Cash Flow	-17.35	-89.48	60.98	2.08	6.07	84.35
Free Cash Flow	63.71	182.8	-70.85	-108.93	-108.97	-72.96
Free Cash Flow Margin	30.45%	42.08%	-118.08%	-409.81%	-398.31%	-254.84%
Free Cash Flow Per Share	0.99	2.81	-1.25	-2.22	-2.35	-2.12
Cash Interest Paid	-	-	-	-	-	0.44
Cash Income Tax Paid	1.53	1.53	-	-	-	-
Levered Free Cash Flow	53.1	65.11	-43.31	-60.37	-61.59	-23.42
Unlevered Free Cash Flow	53.1	65.11	-43.31	-60.37	-61.59	-23.04
Change in Working Capital	-18.85	-122.61	-19.51	-7.77	-3.31	-19.02

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q